Filing Details
- Accession Number:
- 0001570562-18-000131
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-17 21:52:11
- Reporting Period:
- 2018-12-14
- Accepted Time:
- 2018-12-17 21:52:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1570562 | Evolus Inc. | EOLS | Pharmaceutical Preparations (2834) | 461385614 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1730037 | Kristine Romine | 520 Newport Center Dr. Suite 1200 Newport Beach CA 92660 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-12-14 | 11,000 | $12.50 | 35,347 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-17 | 5,000 | $12.75 | 40,347 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The shares were purchased in multiple trades at prices ranging from $12.35 to $12.70. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
